Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projects/755-ibcsg-55-17-touch-phase-ii-open-label-multicenter-randomized-trial-of-neo-adjuvant-palbociclib-in-combination-with-hormonal-therapy-and-her2-blockade-versus-paclitaxel-in-combination-with-her2-blockade-for-elderly-patients-with-hormone-receptor-positiveher2-positive-early-breast-cancer/publications